EvoGenix Limited Touts Positive Bone Treatment Results Published: Jan 16, 2006 EvoGenix (ASX:EGX) has reported results on the development of its product OVP, for the treatment of bone loss. Related links Australian Biotechnology News [Sub. Req.] This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news